US Patent No. 9,428,725

Compositions and methods for capture and elution of biological materials via particulates
Sep 01, 2016

Claremont BioSolutions has been awarded US Patent No. 9,428,725, "Compositions and methods for capture and elution of biological materials via particulates."

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.